Epidemiology


Etiology


Pathophysiology

Menstrual irregularities and amenorrhea

  • ↓ Ovarian function from age-related ovarian follicle loss leads to:
    • ↓ Estrogen and progesterone levels → loss of negative feedback on the pituitary gland → ↑ GnRH levels → ↑ FSH and LH levels (hypergonadotropic hypogonadism)
    • ↑ In anovulatory cycles
      • As the ovaries age, they become less responsive to gonadotropin stimulation.
  • Ovarian function eventually ceases.
  • Iatrogenic removal of the ovaries leads to abrupt cessation of ovarian function.

Vasomotor symptoms

  • Hypothalamic thermoregulatory zone narrows → small temperature changes trigger compensatory reactions
  • ↓ Estrogen is associated with ↑ norepinephrine and ↓ serotonin

Genitourinary symptoms

  • Hypoestrogenism → vaginal and vulvar epithelial atrophy, as well as urethral and bladder atrophy
    • Estrogen has positive effects on collagen and the epithelial surface.

Clinical features

Menstrual abnormalities

  • Irregular menses that gradually decrease in frequency until complete amenorrhea

Vasomotor symptoms of menopause (VMS)

  • Increased sweating
  • Hot flashes
  • Heat intolerance
  • Seen in ∼ 75% of individuals during perimenopause and menopause
  • On average, vasomotor symptoms last for ∼ 7 years.

Other symptoms

  • Osteoporosis
    • Develops at least 10-15 years after cessation of menses

Diagnostics

Supportive studies to confirm menopause

  • FSH: ↑↑; however, levels widely fluctuate during perimenopause
  • Estradiol: ↓
  • Rarely tested for as not routinely recommended: ↓ progesterone, ↓ inhibin B, and ↓ antimüllerian hormone

Studies to exclude differential diagnoses of menopause


Treatment